EP1066311A4 - COMPOSITIONS AND METHODS FOR IDENTIFYING LUNG TUMOR CELLS - Google Patents
COMPOSITIONS AND METHODS FOR IDENTIFYING LUNG TUMOR CELLSInfo
- Publication number
- EP1066311A4 EP1066311A4 EP99914285A EP99914285A EP1066311A4 EP 1066311 A4 EP1066311 A4 EP 1066311A4 EP 99914285 A EP99914285 A EP 99914285A EP 99914285 A EP99914285 A EP 99914285A EP 1066311 A4 EP1066311 A4 EP 1066311A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- compositions
- identification
- methods
- tumor cells
- lung tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03002096A EP1310556A3 (en) | 1998-03-31 | 1999-03-30 | Composition and methods for the identification of lung tumor cells |
EP06026756A EP1790717A3 (en) | 1998-03-31 | 1999-03-30 | Compositions and methods for the identification of lung tumor cells |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8003798P | 1998-03-31 | 1998-03-31 | |
US80037P | 1998-03-31 | ||
PCT/US1999/006938 WO1999050278A1 (en) | 1998-03-31 | 1999-03-30 | Compositions and methods for the identification of lung tumor cells |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03002096A Division EP1310556A3 (en) | 1998-03-31 | 1999-03-30 | Composition and methods for the identification of lung tumor cells |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1066311A1 EP1066311A1 (en) | 2001-01-10 |
EP1066311A4 true EP1066311A4 (en) | 2002-04-10 |
Family
ID=22154860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99914285A Withdrawn EP1066311A4 (en) | 1998-03-31 | 1999-03-30 | COMPOSITIONS AND METHODS FOR IDENTIFYING LUNG TUMOR CELLS |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1066311A4 (ja) |
JP (1) | JP2002509707A (ja) |
AU (1) | AU757478C (ja) |
CA (1) | CA2323833A1 (ja) |
WO (1) | WO1999050278A1 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3217599A (en) | 1998-03-31 | 1999-10-18 | Genzyme Corporation | Methods for the diagnosis and treatment of lung cancer |
WO2001072775A2 (en) * | 2000-03-29 | 2001-10-04 | Diadexus, Inc. | Polynucleotides and polypeptides as well as methods for diagnosing and treating lung cancer |
EP1358349A2 (en) * | 2000-06-05 | 2003-11-05 | Avalon Pharmaceuticals | Cancer gene determination and therapeutic screening using signature gene sets |
AU2002355963A1 (en) | 2001-08-16 | 2003-03-03 | Genzyme Corporation | Molecular characteristics of non-small cell lung cancer |
JP2005531281A (ja) * | 2001-11-02 | 2005-10-20 | ファイザー・プロダクツ・インク | 肺癌の治療および診断 |
WO2006056080A1 (en) * | 2004-11-29 | 2006-06-01 | Diagnocure Inc. | Gpx2 a specific and sensitive target for lung cancer diagnosis, prognosis and/or theranosis |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997042211A1 (en) * | 1996-05-06 | 1997-11-13 | Chiron Corporation | Mammalian sex comb on midleg (mammalian scm) acts as a tumor suppressor |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE68928728T2 (de) * | 1988-01-21 | 1998-12-10 | Massachusetts Eye & Ear Infirm | Diagnose von retinoblastoma |
AU3548289A (en) * | 1988-04-15 | 1989-11-03 | Biogen, Inc. | Processes for purifying phospholipase a2 and producing phospholipase a2-like polypeptides |
AU4809290A (en) * | 1988-11-18 | 1990-06-12 | General Hospital Corporation, The | A camp-responsive transcriptional enhancer binding protein |
US5188964A (en) * | 1990-04-12 | 1993-02-23 | Board Of Regents, The University Of Texas System | Method and kit for the prognostication of breast cancer patient via heat shock/stress protein determination |
US5830464A (en) * | 1997-02-07 | 1998-11-03 | Fordham University | Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy |
-
1999
- 1999-03-30 AU AU32168/99A patent/AU757478C/en not_active Expired
- 1999-03-30 CA CA002323833A patent/CA2323833A1/en not_active Abandoned
- 1999-03-30 JP JP2000541180A patent/JP2002509707A/ja active Pending
- 1999-03-30 WO PCT/US1999/006938 patent/WO1999050278A1/en active IP Right Grant
- 1999-03-30 EP EP99914285A patent/EP1066311A4/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997042211A1 (en) * | 1996-05-06 | 1997-11-13 | Chiron Corporation | Mammalian sex comb on midleg (mammalian scm) acts as a tumor suppressor |
Non-Patent Citations (8)
Title |
---|
BACHER N ET AL.: "Isolation and characterzation of PKC-L, a new member of the protein kinase C-related gene family specifically expressed in lung, skin and heart.", MOLECULAR CELL BIOLOGY, vol. 11, no. 1, January 1991 (1991-01-01), XP001032543 * |
BIRRER MJ AND BROWN PH: "Application of molecular genetics to the early diagnosis and screening of lung cancer", CANCER RESEARCH., vol. 52, no. suppl, 1 May 1992 (1992-05-01), AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD., US, pages 2658s - 2664s, XP002180205, ISSN: 0008-5472 * |
DATABASE GENBANK E.B.I. Hinxton U.K.; 17 February 1997 (1997-02-17), ZSCHUNKE F: "Serine Esterase", XP002179576 * |
DATABASE GENBANK E.B.I. Hinxton U.K.; 18 May 1994 (1994-05-18), HALLEWELL RA: "Mouse Manganese Superoxide Dismutase", XP002179578 * |
DATABASE GENBANK E.B.I. Hinxton, U.K.; 27 April 1993 (1993-04-27), LONG RM: "Human Liver Carboxylesterase isoezyme", XP002179577 * |
SALGIA R AND SKARIN AT: "Molecular abnormalities in lung cancer", JOURNAL OF CLINICAL ONCOLOGY, vol. 16, no. 3, March 1998 (1998-03-01), PHILADELPHIA, PA, US, pages 1207 - 1217, XP001030483 * |
See also references of WO9950278A1 * |
VAN ZANDWIJK N AND VAN 'T VEER L: "The role of prognostic factors and oncogenes in the detection and management of Non-Small-Cell Lung Cancer", ONCOLOGY., vol. Supplement 2, January 1998 (1998-01-01), S. KARGER AG, BASEL., CH, pages 55 - 59, XP001031838, ISSN: 0030-2414 * |
Also Published As
Publication number | Publication date |
---|---|
WO1999050278A1 (en) | 1999-10-07 |
AU757478B2 (en) | 2003-02-20 |
AU757478C (en) | 2004-03-25 |
EP1066311A1 (en) | 2001-01-10 |
CA2323833A1 (en) | 1999-10-07 |
JP2002509707A (ja) | 2002-04-02 |
AU3216899A (en) | 1999-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2212299A (en) | Compositions and methods for the treatment of tumor | |
AU3905399A (en) | Methods and compositions for transgene identification | |
PL354093A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
IL139247A0 (en) | Hematopoietic stimulation | |
IL141403A0 (en) | Deleted adenoviruses and methods of making and administering the same | |
AU2003200731A1 (en) | Compositions and methods for the treatment of tumor | |
AU2003200722A1 (en) | Compositions and methods for the treatment of tumor | |
AU2003200740A1 (en) | Compositions and methods for the treatment of tumor | |
AU2495200A (en) | Compositions and methods for the treatment of tumor | |
KR100510795B1 (en) | Compositions and Methods for the Treatment of Tumor | |
GB2361996B (en) | Multiple marker characterization of single cells | |
AP2000002010A0 (en) | Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof | |
EP1056456A4 (en) | R-LANSOPRAZOL COMPOSITIONS AND TREATMENTS THEREFOR | |
EP1119365A4 (en) | COMPOSITIONS AND METHODS FOR USING TUMOR CELLS | |
HK1039495A1 (en) | Propylene homopolymers and methods of making the same | |
IL145520A0 (en) | Flame-retarding composition and process for the preparation thereof | |
ZA200006300B (en) | Composition comprising tumor cells and extracts and method of using thereof. | |
IL114119A0 (en) | Compositions and methods for the treatment of tumors | |
IL141426A0 (en) | Compositions and methods for the treatment of tumor | |
IL143212A0 (en) | Compositions and methods for the treatment of tumor | |
EP1073333A4 (en) | S-RABEPRAZOL COMPOSITIONS AND METHODS | |
EP1066311A4 (en) | COMPOSITIONS AND METHODS FOR IDENTIFYING LUNG TUMOR CELLS | |
EP1080225A4 (en) | COMPOSITIONS AND METHODS FOR THE PULMONAL ADMINISTRATION OF NUCLEIC ACIDS | |
EP1139981A4 (en) | COMPOSITIONS AND RELATED METHODS OF USE | |
HUP0102850A2 (hu) | Eljárások és kompozíciók fehérje funkcióinak meghatározására és módosítóinak azonosítására |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000929 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20020225 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20020530 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20030503 |